Lataa...
4CPS-071 Therapeutic drug monitoring and safety of high-dose amikacin in critically ill patients
BACKGROUND: Pharmacokinetic parameters are altered in critically ill patients, such as an increase in volume of distribution of hydrophillic drugs. Peak plasma levels of amikacin, a concentration-dependent antibiotic, could be reduced in critically ill patients. Therefore, current recommendations in...
Tallennettuna:
| Julkaisussa: | Eur J Hosp Pharm |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMJ Group
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535322/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.162 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|